Trial Profile
A Prospective Randomized Trial Comparing Two Standard Doses of Enoxaparin for the Prevention of Thromboembolism in Surgical Patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Apr 2024
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- 10 Nov 2023 Planned End Date changed from 31 Mar 2023 to 31 Mar 2025.
- 10 Nov 2023 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2024.
- 14 Apr 2022 Planned End Date changed from 1 Dec 2021 to 31 Mar 2023.